#HIVPrevention #KenyaHealth #Lenacapavir
www.afro.who.int
Kenya becomes first in East Africa to launch six-month HIV prevention injection | WHO | Regional Office for Africa
When a friend's father urgently needed a blood donation, Samson Mutua had to say no. He had been engaging in "risky behaviour" and had never tested for HIV.
#HIV #Healthcare #ClinicalTrials
www.yahoo.com
ViiV's four-monthly HIV drug maintains viral suppression at 12 months
Add Yahoo as a preferred source to see more of our stories on Google.
ViiV Healthcare's investigational four-monthly HIV drug maintains viral suppression at 12 months in a Phase IIb trial.
#HIV #pohlavněpřenosnéchoroby #prevence
tn.nova.cz
V Česku roste počet případů pohlavních nemocí. Rekordně přibylo lidí s HIV | TN.cz
V Česku loni přibyl rekordní počet HIV pozitivních lidí, a to konkrétně 293. Na vzestupu není jen AIDS, ale i další pohlavně přenosné choroby, jako jsou třeba chlamydie anebo kapavka.
N
#HIVPrevention #DigitalHealth #CommunityHealth
www.nih.gov
NIH-supported trial reduces HIV incidence by 70% in rural populations
Study used technology to extend reach of existing infrastructure, linking people to care.
A study funded by the National Institutes of Health (NIH) reduced new HIV cases by 70% in rural Kenya and Uganda by pairing digital tools with tailored HIV services delivered by community health workers and clinicians.
#HIV #léčba #prevence #dobrezpravy
plus.rozhlas.cz
Virolog Cihlář patří k nejvlivnějším lidem světa. "Náš lék může významně přispět k omezení počtu nových infekcí HIV," říká | Plus
"Ve Spojených státech, v Evropě a v řadě dalších zemí je dnes lenakapavir dostupný, může se používat jak k léčbě, tak k prevenci HIV," vysvětluje virolog, jehož tým nový lék vyvinul.
#HIV #Healthcare #LongActingInjectables
markets.businessinsider.com
ViiV Healthcare says Cabenuva demonstrated superior efficacy in LATITUDE trial
GSK (GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer (PFE) and Shionogi (SGIOY) as shareholders, announced final data from the LATITUDE phase III trial, confirming its long-acting injectable treatment for HIV, Cabenuva, demonstrated superior efficacy in maintaining viral load suppression compared to daily oral therapy in individuals with a history of antiretroviral treatment adherence challenges.
#HIVAIDS #BlackLGBTQ #PublicHealth
www.yahoo.com
How Black communities protected each other during the early days of the AIDS crisis
Add Yahoo as a preferred source to see more of our stories on Google.
In the early days of the AIDS crisis, there were no treatments for people with HIV and no pre-exposure prophylaxis (PrEP), a prescription-based daily pill or an injection that people not living with HIV can take to prevent HIV infection, to prevent its spread.
#PublicHealth #HIVPrevention #FederalFunding
www.yahoo.com
Illinois sues Trump administration over more than $100 million in planned cuts to health care grants
Add Yahoo as a preferred source to see more of our stories on Google.
President Donald Trump's administration is moving to cut more than $100 million in federal health care grants for Illinois, a step that was quickly met with a lawsuit filed by Attorney General Kwame Raoul and his peers in three other states.
#PublicHealth #HIVAwareness #ColoradoNews
www.cbsnews.com
Some providers in Colorado concerned about cuts in public health funding
Your Reporter Sarah Horbacewicz specializes in covering stories in Boulder and Broomfield counties. Share you story ideas with her by sending an email to yourreporter@cbs.
W
#Fiji #HIVcrisis #DrugAddiction
www.washingtonpost.com
On a paradise island in the Pacific, meth and HIV epidemics rage
SUVA, Fiji -- The methamphetamine drop-offs to a squatter settlement here followed a routine.
Once a week, according to residents, a black Dodge truck with tinted windows pulled up to a tent on the edge of the community, a dense maze of tiny shacks connected by muddy paths, slick from the persistent summer rain.
